Background*

Dr. Hubertus Erlen serves as the Chairman at Schering Berlin Inc. . He has been the Vice Chairman and Member of the Supervisory Board of SCHERING AKTIENGESELLSCHAFT ( Bayer Schering Pharma AG\Bayer Pharma AG) since September 14, 2006. He serves as a Member of European Advisory Board at Bridgepoint Advisers Limited. Dr. Erlen also serves as a Member of the Supervisory Boards of Partner für Berlin Gesellschaft für Hauptstadt-Marketing mbH; and Kuratorium Bertelsmann Stiftung. ... He serves as a Member of Supervisory Board and Member of Advisory Board at Schaeffler (UK) Ltd. Dr. Erlen advises the Board on broad matters of strategy and to give Bridgepoint's executives an external perspective on all their activities. He served as the Chief Executive Officer at Bayer Pharma AG from 2001 to 2006. He served as the Chairman of the Executive Board of Schering Aktiengesellschaft since April 2001. Dr. Erlen also served as a Member of Executive Board of Schering Aktiengesellschaft since joining in 1985. He spent more than 30 years employed at Schering, including Chief Executive Officer from 2001 to 2006. Dr. Erlen was responsible for strategy, business development, corporate communication, senior executives, and corporate auditing. Dr. Erlen began his career at Schering AG in 1972 in a pharmaceutical manufacturing function. In 1978, he joined the central office of the Executive Board, which he headed for two years. He served as a Member of Supervisory Board of Schaeffler AG. He served as a Member of Central Advisory Board at Commerzbank AG. He served as a Member of Supervisory Board at Schaeffler Technologies AG & Co. KG. He served as a Member of the Supervisory Board at Celesio AG since March 27, 2002 until May 16, 2013. He served as a Member of The Supervisory Board at B. Braun Melsungen AG. He served as a Member of the Electroplating Divisional Board. Dr. Erlen served as a Member of the Supervisory Board of Medrad Inc. until October 4, 2002.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.